What is the recommended amoxicillin regimen for Enterococcus faecalis (E. faecalis) urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Regimen for Enterococcus faecalis UTI

For Enterococcus faecalis urinary tract infections, amoxicillin at a dose of 500-875 mg three times daily for 7 days is the recommended first-line treatment when susceptibility is confirmed. 1

Treatment Selection Algorithm

First-Line Options:

  1. Amoxicillin: 500-875 mg orally three times daily for 7 days

    • Preferred for susceptible E. faecalis strains
    • High urinary concentrations make it effective even for some isolates with higher MICs 2
  2. Amoxicillin-clavulanic acid: 500/125 mg orally three times daily for 7 days

    • Alternative first-line option per WHO guidelines 3
    • Note: The addition of clavulanic acid provides no additional benefit for E. faecalis (which rarely produces beta-lactamases) 4

Alternative Options (if amoxicillin resistance confirmed):

  1. Nitrofurantoin: 100 mg orally twice daily for 5-7 days

    • Effective for lower UTIs only (not for pyelonephritis)
    • Good activity against E. faecalis 1, 5
  2. Fosfomycin: 3 g single oral dose

    • Convenient single-dose therapy
    • Active against many resistant enterococci 1, 5

Special Considerations

Severity-Based Approach:

  • Uncomplicated lower UTI: Oral amoxicillin is appropriate
  • Complicated UTI/Pyelonephritis: Consider parenteral therapy initially
    • Ampicillin 2 g IV every 6 hours 3
    • Switch to oral therapy when clinically improved

Resistance Patterns:

  • E. faecalis generally remains susceptible to ampicillin/amoxicillin (unlike E. faecium) 6
  • For ampicillin-resistant strains, consider:
    • Vancomycin (if susceptible)
    • Linezolid or daptomycin for severe infections 7, 5

Important Caveats:

  • Do not use fluoroquinolones as empiric therapy for E. faecalis UTIs due to high resistance rates (47% resistance to ciprofloxacin reported) 6
  • Avoid cephalosporins as enterococci are intrinsically resistant
  • Distinguish colonization from infection before initiating therapy, especially in catheterized patients 5
  • Remove indwelling catheters whenever possible to improve treatment outcomes 7

Monitoring and Follow-up

  • Clinical response should be assessed within 48-72 hours
  • Repeat urine culture only if symptoms persist after appropriate therapy
  • Consider infectious disease consultation for vancomycin-resistant enterococci (VRE) 1

Duration of Therapy

  • Uncomplicated lower UTI: 5-7 days
  • Complicated UTI or pyelonephritis: 10-14 days

The high urinary concentrations of amoxicillin (exceeding serum levels by 10-100 times) make it particularly effective for treating E. faecalis UTIs, even when in vitro susceptibility testing suggests resistance based on serum breakpoints 2.

References

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aminopenicillins for treatment of ampicillin-resistant enterococcal urinary tract infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.